Semler Scientific (SMLR) Stock Price, News & Analysis

Company Overview

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Key Stats

• Today's Range: $35.40 to $38.18
• 50-Day Range: $28.53 to $45.97
• 52-Week Range: $21.77 to $81.56
• Volume: 580,350 shs
• Average Volume: 676,605 shs
• Market Capitalization: $534.90 million
• P/E Ratio: 14.87
• Dividend Yield: N/A
• Price Target: $81.75
• Consensus Rating: Buy

Semler Scientific Stock Analysis - MarketRank™

Semler Scientific scored higher than 65% of companies evaluated by MarketBeat, and ranked 338th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Buy

Consensus Rating

Semler Scientific has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Semler Scientific has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Semler Scientific is 14.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.88.

Price to Earnings Ratio vs. Sector

The P/E ratio of Semler Scientific is 14.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.06.

Price to Book Value per Share Ratio

Semler Scientific has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

17.54% of the float of Semler Scientific has been sold short.

Short Interest Ratio / Days to Cover

Semler Scientific has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Semler Scientific has recently decreased by 1.06%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Semler Scientific does not currently pay a dividend.

Dividend Growth

Semler Scientific does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

17.54% of the float of Semler Scientific has been sold short.

Short Interest Ratio / Days to Cover

Semler Scientific has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Semler Scientific has recently decreased by 1.06%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.23

News Sentiment

Semler Scientific has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Semler Scientific this week, compared to 5 articles on an average week.

Search Interest

12 people have searched for SMLR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

4 people have added Semler Scientific to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Semler Scientific insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.40% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

49.37% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SMLR Stock Analysis - Frequently Asked Questions

How have SMLR shares performed this year?

Semler Scientific's stock was trading at $54.00 at the beginning of 2025. Since then, SMLR stock has decreased by 33.1% and is now trading at $36.13.

How were Semler Scientific's earnings last quarter?

Semler Scientific Inc. (NASDAQ:SMLR) issued its quarterly earnings data on Monday, August, 4th. The company reported $5.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $5.31. The firm had revenue of $8.22 million for the quarter, compared to analysts' expectations of $8.10 million. Semler Scientific had a net margin of 86.20% and a trailing twelve-month return on equity of 43.84%.
Read the conference call transcript.

Who are Semler Scientific's major shareholders?

Top institutional investors of Semler Scientific include Interchange Capital Partners LLC (9.31%), Geode Capital Management LLC (1.45%), Deltec Asset Management LLC (0.74%) and Generali Asset Management SPA SGR (0.51%). Insiders that own company stock include Eric Semler and Douglas Murphy-Chutorian.
View institutional ownership trends.

How do I buy shares of Semler Scientific?

Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Semler Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Semler Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Arista Networks (ANET) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 8/04/2025
• Today: 8/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SMLR
• CIK: 1554859
• Web: www.semlerscientific.com
• Phone: 877-774-4211
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Semler Scientific: $81.75
• High Price Target: $101.00
• Low Price Target: $60.00
• Potential Upside/Downside: +126.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.43
• Trailing P/E Ratio: 14.87
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $40.90 million
• Net Margins: 86.20%
• Pretax Margin: 103.88%
• Return on Equity: 43.84%
• Return on Assets: 32.88%

Debt

• Debt-to-Equity Ratio: 0.25
• Current Ratio: 0.60
• Quick Ratio: 0.51

Sales & Book Value

• Annual Sales: $56.29 million
• Price / Sales: 9.51
• Cash Flow: $4.48 per share
• Price / Cash Flow: 8.07
• Book Value: $25.90 per share
• Price / Book: 1.39

Miscellaneous

• Outstanding Shares: 14,810,000
• Free Float: 12,377,000
• Market Cap: $535.09 million
• Optionable: Not Optionable
• Beta: 1.34